{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T07:17:11Z","timestamp":1779261431201,"version":"3.51.4"},"reference-count":31,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T00:00:00Z","timestamp":1489363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovascular Therapeutics"],"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Percutaneous coronary intervention (<jats:styled-content style=\"fixed-case\">PCI<\/jats:styled-content>) with early\u2010generation drug\u2010eluting stent (<jats:styled-content style=\"fixed-case\">eDES<\/jats:styled-content>) implantation for ostial right coronary artery (<jats:styled-content style=\"fixed-case\">RCA<\/jats:styled-content>) lesions is challenging because of the frequent need for repeat revascularization. We compared midterm clinical outcomes following <jats:styled-content style=\"fixed-case\">eDES<\/jats:styled-content> or new\u2010generation <jats:styled-content style=\"fixed-case\">DES<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">nDES<\/jats:styled-content>) implantation for ostial <jats:styled-content style=\"fixed-case\">RCA<\/jats:styled-content> lesions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The study included 150 patients with ostial <jats:styled-content style=\"fixed-case\">RCA<\/jats:styled-content> lesions, 76 treated with <jats:styled-content style=\"fixed-case\">eDES<\/jats:styled-content> and 74 with <jats:styled-content style=\"fixed-case\">nDES<\/jats:styled-content> between January 2005 and September 2013. Study endpoints were major adverse cardiac events (<jats:styled-content style=\"fixed-case\">MACE<\/jats:styled-content>s), specifically all\u2010cause death, target lesion revascularization (<jats:styled-content style=\"fixed-case\">TLR<\/jats:styled-content>), or myocardial infarction within 2\u00a0years after PCI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Patient characteristics between the groups were similar. The <jats:styled-content style=\"fixed-case\">MACE<\/jats:styled-content> rate was significantly lower in patients treated with <jats:styled-content style=\"fixed-case\">nDES<\/jats:styled-content> compared with those treated with <jats:styled-content style=\"fixed-case\">eDES<\/jats:styled-content>, mainly driven by the lower rates of <jats:styled-content style=\"fixed-case\">TLR<\/jats:styled-content> in the <jats:styled-content style=\"fixed-case\">nDES<\/jats:styled-content> group. Cox regression analysis identified severe chronic kidney disease (<jats:styled-content style=\"fixed-case\">CKD<\/jats:styled-content>) and the use of <jats:styled-content style=\"fixed-case\">nDES<\/jats:styled-content> as the independent predictors of MACE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The implantation of <jats:styled-content style=\"fixed-case\">nDES<\/jats:styled-content> for ostial <jats:styled-content style=\"fixed-case\">RCA<\/jats:styled-content> lesions significantly reduced the <jats:styled-content style=\"fixed-case\">MACE<\/jats:styled-content> rate compared with early\u2010generation <jats:styled-content style=\"fixed-case\">DES<\/jats:styled-content>, mainly driven by a reduction in the <jats:styled-content style=\"fixed-case\">TLR<\/jats:styled-content> rate. However, <jats:styled-content style=\"fixed-case\">nDES<\/jats:styled-content> implantations for ostial <jats:styled-content style=\"fixed-case\">RCA<\/jats:styled-content> lesions may still be challenging in patients with severe CKD.<\/jats:p><\/jats:sec>","DOI":"10.1111\/1755-5922.12247","type":"journal-article","created":{"date-parts":[[2016,12,31]],"date-time":"2016-12-31T10:52:39Z","timestamp":1483181559000},"source":"Crossref","is-referenced-by-count":11,"title":["Comparison of early\u2010 and new\u2010generation drug\u2010eluting stent implantations for ostial right coronary artery lesions"],"prefix":"10.1111","volume":"35","author":[{"given":"Yusuke","family":"Watanabe","sequence":"first","affiliation":[{"name":"Interventional Cardiology Unit New Tokyo Hospital  Chiba Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Takagi","sequence":"additional","affiliation":[{"name":"Interventional Cardiology Unit New Tokyo Hospital  Chiba Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Naganuma","sequence":"additional","affiliation":[{"name":"Interventional Cardiology Unit New Tokyo Hospital  Chiba Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunao","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Interventional Cardiology Unit New Tokyo Hospital  Chiba Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,3,13]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1253\/circj.72.880"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1253\/circj.71.1328"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000121358.26097.06"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(91)90936-4"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1159\/000128602"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12928-013-0236-2"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.12.036"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-11-0814"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.01.023"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03091813"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.02.023"},{"key":"e_1_2_7_13_1","first-page":"304","article-title":"Outcomes with first\u2010 versus second\u2010generation drug\u2010eluting stents in coronary chronic total occlusions (CTOs): a systematic review and meta\u2010analysis","volume":"26","author":"Lanka V","year":"2014","journal-title":"J Invasive Cardiol"},{"key":"e_1_2_7_14_1","first-page":"209","article-title":"Early\u2010generation versus new\u2010generation drug\u2010eluting stents in isolated chronic total occlusion: on the road to extinction?","volume":"26","author":"Jaguszewski M","year":"2014","journal-title":"J Invasive Cardiol"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.05.058"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2007.08.018"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCA.0b013e32830936d4"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV5I7A146"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.685313"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1010-7940(99)00134-7"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2007.134114"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV7I9A170"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.25518"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)01745-X"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199809173391203"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00540.x"},{"key":"e_1_2_7_27_1","first-page":"364","article-title":"Percutaneous coronary intervention in chronic kidney disease patients","volume":"17","author":"Tadros GM","year":"2004","journal-title":"J Nephrol"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(00)00998-X"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000083900.92829.F5"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000121327.67756.19"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi882"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/00019501-200402000-00006"}],"container-title":["Cardiovascular Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1755-5922.12247","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1755-5922.12247","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T12:19:17Z","timestamp":1696335557000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1755-5922.12247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,13]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.1111\/1755-5922.12247"],"URL":"https:\/\/doi.org\/10.1111\/1755-5922.12247","archive":["Portico"],"relation":{},"ISSN":["1755-5914","1755-5922"],"issn-type":[{"value":"1755-5914","type":"print"},{"value":"1755-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,13]]},"article-number":"e12247"}}